பால பிோரவண்தி News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from பால பிோரவண்தி. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In பால பிோரவண்தி Today - Breaking & Trending Today
Attorneys for oil and gas venture Roan Resources Inc. urged a Delaware vice chancellor on Tuesday to toss a shareholder suit challenging its $1 billion sale to a private equity-backed buyer, saying no better deal was available and stockholders overwhelmingly approved. ....
Chancery OKs Trimmed $3.45M Fee In Nutraceutical Sale Suit law360.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from law360.com Daily Mail and Mail on Sunday newspapers.
Zayo CEO Packed Board Ahead Of $14B Deal, Chancery Told law360.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from law360.com Daily Mail and Mail on Sunday newspapers.
Gross v. Biogen Inc ., C.A. No. 2020-0096-PAF (Del. Ch. Apr. 14, 2021). On October 11, 2016, plaintiff Melvin Gross, served the first of four books-and-records demands on defendant Biogen Inc., under DGCL Section 220. Mr. Gross was a stockholder of Biogen at the time he made the demand. The demand sought eight categories of materials in order to: (1) “investigate possible corporate wrongdoing” and mismanagement related to state and federal investigations; and (2) “determine the independence of the Board members.” Biogen rejected the October 2016 demand, contending that it did not meet Section 220’s form and manner requirements, and that Gross lacked a proper purpose to inspect Biogen’s records. Through subsequent books-and-records demands on November 4, 2016, June 21, 2018, and December 3, 2019, Gross attempted to cure the alleged deficiencies, but succeeded only in prompting Biogen to argue that certain of the records sought were neither necessary nor essentia ....
IN THIS ISSUE Biogen Inc. Wins Some, Loses Some, In Delaware Chancery Court Corporate Records Suit; Southern District of Florida Dismisses Securities Fraud Class Action Against Norwegian Cruise Lines Stemming From Alleged Impacts of Covid-19; Ninth Circuit Affirms Dismissal of Securities Fraud Class Action Against Investment Bank; In SEC Enforcement Action Against Ripple Labs, Inc., S.D.N.Y. Court Orders Government To Turn Over Documents Discussing Whether Bitcoin, Ether, or XRP Are “Securities”; In Unusual About-Face, Federal Prosecutors Drop Securities Fraud Case Against Former Brixmor Property Group Inc. Executives.
On April 14, 2021, in Melvin Gross v. Biogen Inc., C.A No. 2020-0096 (Del. Ch), Vice Chancellor Paul A. Fioravanti issued a post-trial opinion granting Biogen Inc. (“Biogen”) stockholder, Melvin Gross (“Gross”), the ability to inspect a wide range of the company’s books and records, while denying him access to others. Specifically, ....